Publisher Full Text
Of chloroquine and COVID-19.Antiviral Res. 2020 05; 177:104762.AR
Abstract
Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.
Links
MeSH
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
32147496
Clinical Trial Links
Citation
Touret, Franck, and Xavier de Lamballerie. "Of Chloroquine and COVID-19." Antiviral Research, vol. 177, 2020, p. 104762.
Touret F, de Lamballerie X. Of chloroquine and COVID-19. Antiviral Res. 2020;177:104762.
Touret, F., & de Lamballerie, X. (2020). Of chloroquine and COVID-19. Antiviral Research, 177, 104762. https://doi.org/10.1016/j.antiviral.2020.104762
Touret F, de Lamballerie X. Of Chloroquine and COVID-19. Antiviral Res. 2020;177:104762. PubMed PMID: 32147496.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Of chloroquine and COVID-19.
AU - Touret,Franck,
AU - de Lamballerie,Xavier,
Y1 - 2020/03/05/
PY - 2020/02/29/received
PY - 2020/03/02/revised
PY - 2020/03/02/accepted
PY - 2020/3/10/pubmed
PY - 2020/4/24/medline
PY - 2020/3/10/entrez
KW - 2019-nCoV
KW - Antiviral
KW - COVID-19
KW - Chloroquine
KW - SARS-CoV-2
SP - 104762
EP - 104762
JF - Antiviral research
JO - Antiviral Res
VL - 177
N2 - Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.
SN - 1872-9096
UR - https://www.unboundmedicine.com/medline/citation/32147496/full_citation
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0166-3542(20)30114-5
DB - PRIME
DP - Unbound Medicine
ER -